Exactly TV. So why would shareholders want to stay on the ASX where investors are not making comparisons with like for like companies, rather looking for penny stocks? On top of your comparisons- we have a total of 27 other clinical programs. You have highlighted only one - one that we are conducting clinical trials on + setting up Australia's first dedicated Psychedelic-assisted psychotherapy clinics. When the doors open to Clarion Clinics in a couple months, this will be world news, the talk needs to be on the NASDAQ- not the ASX which time & time again gives IHL a red day on a booming announcement. Additionally OSA trials will commence in the USA shortly seeking FDA approval this will be massive news maker in the USA & Australia wont even care. If you want a penny stock , sell & chase something else. If you want a world leading American listed company with Australian heritage stick around & enjoy the story.
IHL Price at posting:
10.8¢ Sentiment: Buy Disclosure: Held
